{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:08:49Z","timestamp":1780805329165,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22926007"],"award-info":[{"award-number":["22926007"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25928012"],"award-info":[{"award-number":["25928012"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.dmpk.2015.08.008","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T10:30:53Z","timestamp":1441276253000},"page":"419-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["CYP3A activity based on plasma 4\u03b2-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-3789","authenticated-orcid":false,"given":"Takafumi","family":"Naito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kubono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2015.08.008_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/sper.2001.24565","article-title":"Physiologic changes in pregnancy and their effect on drug disposition","volume":"25","author":"Frederiksen","year":"2001","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmpk.2015.08.008_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","article-title":"Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy","volume":"192","author":"Tracy","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-pharmtox-011613-140009","article-title":"Pharmacometrics in pregnancy: an unmet need","volume":"54","author":"Ke","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0009-9236(98)90084-4","article-title":"Urinary excretion of 6\u03b2-hydroxycortisol as an in\u00a0vivo marker for CYP3A induction: applications and recommendations","volume":"63","author":"Kovacs","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2015.08.008_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2125.2010.03773.x","article-title":"4\u03b2-Hydroxycholesterol, an endogenous marker of CYP3A4\/5 activity in humans","volume":"71","author":"Diczfalusy","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2125.2008.03309.x","article-title":"4\u03b2-Hydroxycholesterol as an endogenous marker for CYP3A4\/5 activity. Stability and half-life of elimination after induction with rifampicin","volume":"67","author":"Diczfalusy","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/clpt.2008.132","article-title":"Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4\u03b2-hydroxycholesterol","volume":"84","author":"Kanebratt","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2015.08.008_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00228-008-0492-8","article-title":"CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4\u03b2-hydroxycholesterol levels","volume":"64","author":"Josephson","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.5414\/CPP47709","article-title":"4\u03b2-Hydroxycholesterol as a marker of CYP3A4 inhibition in\u00a0vivo \u2013 effects of itraconazole in man","volume":"47","author":"L\u00fctjohann","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2015.08.008_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/dmd.113.054171","article-title":"Association of plasma concentration of 4\u03b2-hydroxycholesterol with CYP3A5 polymorphism and plasma concentration of indoxyl sulfate in stable kidney transplant recipients","volume":"42","author":"Suzuki","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2015.08.008_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00228-010-0984-1","article-title":"Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4\u03b2-hydroxycholesterol","volume":"67","author":"Nyl\u00e9n","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib13","doi-asserted-by":"crossref","first-page":"f894","DOI":"10.1136\/bmj.f894","article-title":"Postpartum management of hypertension","volume":"346","author":"Bramham","year":"2013","journal-title":"Br Med J"},{"key":"10.1016\/j.dmpk.2015.08.008_bib14","first-page":"38","article-title":"Use of antihypertensive drugs during pregnancy and lactation","volume":"26","author":"Ghanem","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.dmpk.2015.08.008_bib15","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1021\/jm00110a012","article-title":"Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4","volume":"34","author":"Guengerich","year":"1991","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.dmpk.2015.08.008_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2125.1986.tb02874.x","article-title":"The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily","volume":"22","author":"Faulkner","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clpt.2005.04.005","article-title":"Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers","volume":"78","author":"Glesby","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2015.08.008_bib18","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/AAC.00653-11","article-title":"Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin","volume":"55","author":"Lee","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.dmpk.2015.08.008_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0890334414560195","article-title":"Amlodipine passage into breast milk in lactating women with pregnancy-induced hypertension and its estimation of infant risk for breastfeeding","volume":"31","author":"Naito","year":"2015","journal-title":"J\u00a0Hum Lact"},{"key":"10.1016\/j.dmpk.2015.08.008_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2131\/jts.32.79","article-title":"Induction of hepatic cytochrome P450 isoforms by nicardipine at therapeutic doses in spontaneously hypertensive rats","volume":"32","author":"Miyajima","year":"2007","journal-title":"J\u00a0Toxicol Sci"},{"key":"10.1016\/j.dmpk.2015.08.008_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.dmpk.2015.08.008_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2015.08.008_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/clpt.2009.72","article-title":"Plasma 4\u03b2-hydroxycholesterol: an endogenous CYP3A metric?","volume":"86","author":"Tomalik-Scharte","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2015.08.008_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0002-9378(79)90469-1","article-title":"The hyperlipidemia of pregnancy in normal and complicated pregnancies","volume":"133","author":"Potter","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/jhh.2008.161","article-title":"The phase III, double-blind, parallel-group controlled study of amlodipine 10\u00a0mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5\u00a0mg once daily","volume":"23","author":"Fujiwara","year":"2009","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.dmpk.2015.08.008_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.phrs.2004.11.006","article-title":"Assessment of sex differences in pharmacokinetics and pharmacodynamics of amlodipine in a bioequivalence study","volume":"51","author":"Abad-Santos","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dmpk.2015.08.008_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-200241050-00002","article-title":"How important are gender differences in pharmacokinetics?","volume":"41","author":"Meibohm","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmpk.2015.08.008_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/dmd.112.049015","article-title":"Induction of hepatic CYP3A enzymes by pregnancy-related hormones: studies in human hepatocytes and hepatic cell lines","volume":"41","author":"Papageorgiou","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2015.08.008_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/dmd.113.055400","article-title":"Amlodipine metabolism in human liver microsomes and roles of CYP3A4\/5 in the dihydropyridine dehydrogenation","volume":"42","author":"Zhu","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2015.08.008_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0005-2760(96)00052-5","article-title":"The oxysterols cholest-5-ene-3\u03b2,4\u03b1-diol, cholest-5-ene-3\u03b2,4\u03b2-diol and cholestane-3\u03b2,5\u03b1,6\u03b1-triol are formed during in\u00a0vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques","volume":"1302","author":"Breuer","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.dmpk.2015.08.008_bib31","doi-asserted-by":"crossref","first-page":"31534","DOI":"10.1074\/jbc.M201712200","article-title":"Metabolism of 4\u03b2-hydroxycholesterol in humans","volume":"277","author":"Bodin","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dmpk.2015.08.008_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/clinchem\/17.3.156","article-title":"Normal clinical chemical values for pregnant women at term","volume":"17","author":"Elliott","year":"1971","journal-title":"Clin Chem"},{"key":"10.1016\/j.dmpk.2015.08.008_bib33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.clpt.2006.09.009","article-title":"Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects","volume":"80","author":"Kim","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2015.08.008_bib34","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1023\/A:1007568811691","article-title":"Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4","volume":"17","author":"Katoh","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.dmpk.2015.08.008_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2125.2006.02733.x","article-title":"Effect of ABCB1 (MDR1) haplotypes derived from G2677T\/C3435T on the pharmacokinetics of amlodipine in healthy subjects","volume":"63","author":"Kim","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2015.08.008_bib36","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/dmd.109.031245","article-title":"Pharmacokinetics of metformin during pregnancy","volume":"38","author":"Eyal","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2015.08.008_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/00498258809041660","article-title":"Metabolism and kinetics of amlodipine in man","volume":"18","author":"Beresford","year":"1988","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2015.08.008_bib38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","article-title":"Pharmacokinetic changes during pregnancy and their clinical relevance","volume":"33","author":"Loebstein","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmpk.2015.08.008_bib39","first-page":"III3","article-title":"Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties","volume":"17","author":"Van Zwieten","year":"1994","journal-title":"Clin Cardiol"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436715000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436715000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:52:47Z","timestamp":1761162767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1347436715000555"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2015.08.008","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP3A activity based on plasma 4\u03b2-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2015.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}